SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-006178
Filing Date
2021-02-17
Accepted
2021-02-17 06:00:37
Documents
13
Period of Report
2021-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20210211.htm   iXBRL 8-K 40198
2 EX-10.1 onct-ex101_8.htm EX-10.1 161744
  Complete submission text file 0001564590-21-006178.txt   363002

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA onct-20210211.xsd EX-101.SCH 5780
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210211_lab.xml EX-101.LAB 19471
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210211_pre.xml EX-101.PRE 11635
6 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20210211_htm.xml XML 3570
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 21642520
SIC: 2834 Pharmaceutical Preparations